Effect of monoclonal antibody therapy on the endogenous SARS-CoV-2 antibody response

Monoclonal antibody treatment of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection has been widely implemented. Effects of treatment on the endogenous primary humoral response to the virus are unknown. A retrospective cohort study performed at a Veterans Health Administration me...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Paul S., Dimcheff, Derek E., Siler, Andrew, Schildhouse, Richard J., Chensue, Stephen W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academic Press 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866167/
https://www.ncbi.nlm.nih.gov/pubmed/35218964
http://dx.doi.org/10.1016/j.clim.2022.108959

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866167/
https://www.ncbi.nlm.nih.gov/pubmed/35218964
http://dx.doi.org/10.1016/j.clim.2022.108959

Ejemplares similares